Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-044233
Filing Date
2025-03-03
Accepted
2025-03-03 17:01:19
Documents
5
Effectiveness Date
2025-03-03

Document Format Files

Seq Description Document Type Size
1 S-8 d889909ds8.htm S-8 44528
2 EX-5.1 d889909dex51.htm EX-5.1 8804
3 EX-23.2 d889909dex232.htm EX-23.2 1233
4 EX-FILING FEES d889909dexfilingfees.htm EX-FILING FEES 16549
5 GRAPHIC g889909g0228093336237.jpg GRAPHIC 2534
  Complete submission text file 0001193125-25-044233.txt   75845
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285514 | Film No.: 25699183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)